Historical record - last NADAC effective date: 7/22/2020
Product Information
RALOXIFENE HCL 60 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.4760 per EA under NDC 65162005711. Its NADAC has been published 212 times since Jul 13, 2016.
FDA first approved this application on Apr 8, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162005711
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/22/2020
Active Ingredients
RALOXIFENE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208206FDA Approved
4/8/2016
TE Code
AB
On Market Since
1/20/2016
Pharmacological Classes
Price Statistics
The NADAC for RALOXIFENE HCL 60 MG TABLET has been published 212 times since Jul 13, 2016, and over the history we have for it it has declined 80.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4760 per EA |
|---|---|
| All-time high | $2.3853 (Jul 13, 2016) |
| All-time low | $0.4756 (Apr 22, 2020) |
| Median price | $0.7478 |
| Average price | $0.9329 |
| Largest weekly change | +31.5% (Jan 22, 2020) |
| Weeks tracked | 212 |
| Tracking since | Jul 13, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-80.0%
Last surveyed Jul 29, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Raloxifene Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen Agonist/Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RALOXIFENE HCL 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RALOXIFENE HCL 60 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.4760 per EA (NDC 65162005711), effective Jul 29, 2020.
How has the price of RALOXIFENE HCL 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for RALOXIFENE HCL 60 MG TABLET has declined 80.0%. It has been tracked across 212 weekly CMS publications since Jul 13, 2016.
What are the highest and lowest recorded NADAC prices for RALOXIFENE HCL 60 MG TABLET?
Since Jul 13, 2016, the NADAC for RALOXIFENE HCL 60 MG TABLET has ranged from a low of $0.4756 (Apr 22, 2020) to a high of $2.3853 (Jul 13, 2016), with a median of $0.7478 per EA.
Are there cheaper alternatives to RALOXIFENE HCL 60 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RALOXIFENE HCL 60 MG TABLET, is $0.2235 per EA — about 53% below RALOXIFENE HCL 60 MG TABLET.
Who manufactures RALOXIFENE HCL 60 MG TABLET?
RALOXIFENE HCL 60 MG TABLET (NDC 65162005711) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.